ScienceIO
121 Mount Vernon St, Boston, Massachusetts, 02108, United States
Overview
ScienceIO is developing a data-first healthcare platform that uses natural language processing and machine learning to turn disparate clinical data into high-quality, computable records. The company says it has spent two to three years assembling what it calls a highly representative dataset and cites over 9 million medical conditions, drugs, devices and genes as potential variables. ScienceIO’s product makes health data more searchable and produces analytics rather than passively tracking patients. The startup is currently running pilot programs with several customers but declined to name them; pilot results will inform a realistic timeline for general availability. Founders include Gaurav Kaushik and CEO Will Manidis, and the team emphasizes a holistic view of patients to surface unmet needs and potential treatments. Financially, the company exited stealth after raising an $8 million seed round.
- Total raised
- $8M
- Funding rounds
- 1
- Latest round
- Seed
- Latest activity
- Oct 2021
Industries
- Analytics
- Artificial Intelligence (AI)
- Health Care
- Natural Language Processing
Recent funding
Seed
Oct 2021
$8M